New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
10:42 EDTGENZ
theflyonthewall.com: Genzyme rises ahead of potential Cerezyme update
Genzyme (GENZ) is rising slightly after Wells Fargo analysts predicted that the company would provide details about the reintroduction of its Cerezyme drug by tomorrow. Wells Fargo noted that Genzyme had promised during a November 16 conference call to release additional details about the resupply of Cerezyme within the next ten days. The analysts think that an effective reintroduction of Cerezyme without any supply interruptions in coming months will be a crucial factor in the company's ability to rebuild trust and brand loyalty. Genzyme interrupted production of the drug last June, after it identified virus in a bioreactor used to produce the product. Wells Fargo contends that such a reintroduction will also be key to limiting the company's competition, and it predicts that Genzyme's stock will advance after Cerezyme's reintroduction. The firm maintains a Market Weight rating on Genzyme. In mid-morning trading, Genzyme gained 54c, or 1.07%, to $50.93. :theflyonthewall.com



News For GENZ From The Last 14 Days
Check below for free stories on GENZ the last two weeks.
There are 10 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 9, 2010
11:00 EDTGENZ
theflyonthewall.com: Genzyme mentioned cautiously at Summer Street

Subscribe for More Information :theflyonthewall.com
06:10 EDTGENZ
theflyonthewall.com: Targeted Genetics receives milestone payments from Genzyme

Subscribe for More Information :theflyonthewall.com

February 8, 2010
09:00 EDTGENZ
theflyonthewall.com: On The Fly: Analysts Upgrade Summary

Subscribe for More Information :theflyonthewall.com
06:35 EDTGENZ
theflyonthewall.com: Genzyme upgraded to Sell from Conviction Sell at Goldman

Subscribe for More Information :theflyonthewall.com

February 5, 2010
11:57 EDTGENZ
theflyonthewall.com: Leerink's Biotech Analysts to hold a conference call

Subscribe for More Information :theflyonthewall.com

February 3, 2010
08:03 EDTGENZ
theflyonthewall.com: Genzyme volatility flat into EPS and outlook

Subscribe for More Information :theflyonthewall.com
06:50 EDTGENZ
theflyonthewall.com: Genzyme upgraded to Buy from Neutral at UBS

Subscribe for More Information :theflyonthewall.com

February 2, 2010
09:18 EDTGENZ
theflyonthewall.com: Genzyme could unlock additional value by divesting units, says Bernstein

Subscribe for More Information :theflyonthewall.com

January 29, 2010
07:56 EDTGENZ
theflyonthewall.com: Biotech firms face middle age, WSJ says

Subscribe for More Information :theflyonthewall.com

January 28, 2010
08:33 EDTGENZ
theflyonthewall.com: Genzyme adopts new incentive plan for senior executives

Subscribe for More Information :theflyonthewall.com